Active Search for Pediatric HIV/AIDS (ASPA)

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT03024762
• Date of registration: 06/12/2016
• Prospective Registration: No
• Primary sponsor: Research for Development International
• Public title: Active Search for Pediatric HIV/AIDS (ASPA) ASPA
• Scientific title: Active Search for Pediatric HIV/AIDS (ASPA)
• Date of first enrolment: July 2015
• Target sample size: 870
• Recruitment status: Active, not recruiting
• URL: https://clinicaltrials.gov/show/NCT03024762
• Study type: Interventional
• Study design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Cameroon

Contacts

• Name: Habakkuk Yumo, MD, MPH
• Affiliation: Research for Development International

Key inclusion & exclusion criteria

Inclusion Criteria:

- HIV-infected parents: Parents diagnosed with HIV infection or receiving HIV services
in the hospital and consenting to participate will be eligible for enrollment in the
study.

- Parents/guardians seeking care for their children in the hospital: Parents/guardians
presenting at the hospital with sick children will be enrolled in the study
irrespective of the motive of consultations for their children.

- Children of HIV infected parents: children of HIV infected parents aged between 6
weeks to 19 years old will be eligible for enrollment in the study. Parents/guardians
consent will be required as well as assent of older kids.

- Children consulting in the hospital: Children aged 6 weeks to 19 years old consulting
in the hospital for any reason will be eligible to participate in the study.
Parents/guardians consent will be required as well as assent of older kids.

- HIV infected children: children (6weeks the hospital at least 2 years before the beginning of the project and after this
beginning will be enrolled into the study to assess retention into care and factors
associated with loss to follow up.

- Health personnel: Health personnel involved in children's consultations and consenting
to participate will be enrolled in the study.

Exclusion Criteria:

- Refusal to participate: health personnel, parents/guardians, children not willing to
participate will be excluded from the study

- HIV Status: Children with known HIV positive status will be excluded for HIV testing

- Age: Children below the age of 6 weeks or above 19 years will be excluded from the
study

- Health conditions: parents who are critically ill or mentally unstable will be
excluded from the study



Age minimum: 6 Weeks
Age maximum: 19 Years
Gender: All

Health Condition(s) or Problem(s) studied

Pediatric HIV Infection

Intervention(s)

Procedure: targeted Provider-Initiated-Testing and Counseling (tPITC)

Primary Outcome(s)

Yield [Time Frame: 6 months]

Secondary Outcome(s)

Combined effect (tPITC+bPITC) [Time Frame: 6 months]

Acceptability [Time Frame: 6 months]

feasibility [Time Frame: 6 months]

Retention [Time Frame: 24 months]

Linkage [Time Frame: 6 months]

Prevalence [Time Frame: 6 months]

Secondary ID(s)

R4D0007/2015

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Else Kröner Fresenius Foundation

Albert Einstein College of Medicine, Inc.